Infectex , a resident of the Skolkovo Foundation’s biomed cluster, has completed clinical trials in Russia of its new drug for treating TB, the company announced on Friday, World Tuberculosis Day. The drug – SQ109 – has demonstrated high...
На Петербургском международном экономическом форуме компания IBM, Фонд «Сколково» и Первый Онкологический Научно-Консультационный Центр (ПОНКЦ) подписали меморандум о взаимопонимании. Документ предусматривает формирование первого в своем роде стратегического...
ExoAtlet , a Skolkovo startup that makes medical exoskeletons for the rehabilitation of disabled people, has started clinical research into the use of its exoskeletons to help people with multiple sclerosis. An ExoAtlet exoskeleton being demonstrated...
Skolkovo resident DRD Biotech has unveiled its testing kits for swiftly determining the risk of a stroke. DRD Biotech presented its testing kits in the company's hometown of Ulan-Ude, capital of Russia's Buryatia republic . The tests are...